UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

An integrated study of threonine-pathway enzyme kinetics in Escherichia coli

Biochemical journal, 2001-06, Vol.356 (Pt 2), p.415-423

2001

Link zum Volltext

Verfügbarkeit prüfen

Dynamic modeling of the central carbon metabolism of Escherichia coli

Biotechnology and bioengineering, 2002-07, Vol.79 (1), p.53-73

2002

Link zum Volltext

Verfügbarkeit prüfen

Control of the threonine-synthesis pathway in Escherichia coli: a theoretical and experimental approach

Biochemical journal, 2001-06, Vol.356 (Pt 2), p.433-444

2001

Link zum Volltext

Verfügbarkeit prüfen

565 The Virtual Tumour, a predictive simulation platform to optimize anti-cancer drug scheduling and combination

European journal of cancer supplements, 2010, Vol.8 (7), p.178-179

2010

Link zum Volltext

Verfügbarkeit prüfen

Using a mammalian cell cycle simulation to interpret differential kinase inhibition in anti-tumour pharmaceutical development

BioSystems, 2006-02, Vol.83 (2), p.91-97

2006

Link zum Volltext

Verfügbarkeit prüfen

Threonine synthesis from aspartate in Escherichia coli cell-free extracts: pathway dynamics

Biochemical journal, 2001-06, Vol.356 (Pt 2), p.425-432

2001

Link zum Volltext

Verfügbarkeit prüfen

Rational Design of a Corynebacterium glutamicum Pantothenate Production Strain and Its Characterization by Metabolic Flux Analysis and Genome-Wide Transcriptional Profiling

Applied and Environmental Microbiology, 2005-06, Vol.71 (6), p.3255-3268

2005

Link zum Volltext

Verfügbarkeit prüfen

Ketopantoate reductase activity is only encoded by ilvC in Corynebacterium glutamicum

Journal of biotechnology, 2003-09, Vol.104 (1), p.253-260

2003

Link zum Volltext

Verfügbarkeit prüfen

Metabolic network analysis during fed-batch cultivation of Corynebacterium glutamicum for pantothenic acid production: first quantitative data and analysis of by-product formation

Journal of biotechnology, 2003-09, Vol.104 (1-3), p.261-272

2003

Link zum Volltext

Verfügbarkeit prüfen

In silico strategy to rationally engineer metabolite production: a case study for threonine in Escherichia coli

New biotechnology, 2009-09, Vol.25, p.S358-S358

2009

Link zum Volltext

Verfügbarkeit prüfen

Control of threonine pathway in E. coli. Application to biotechnologies

Acta biotheoretica, 1995-12, Vol.43 (4), p.285-297

1995

Link zum Volltext

Verfügbarkeit prüfen

Dynamic simulation of pollutant effects on the threonine pathway in Escherichia coli

Comptes rendus. Biologies, 2003-05, Vol.326 (5), p.501-508

2003

Link zum Volltext

Verfügbarkeit prüfen

Parameters estimation by differential evolutionary algorithms for simulation of metabolic pathways in Escherichia coli

20th International Conference on Advanced Information Networking and Applications - Volume 1 (AINA'06), 2006, Vol.2, p.6 pp.

2006

Link zum Volltext
IEEE_Xplore

Dependence of Control Coefficient Distribution on the Boundaries of a Metabolic System: A Generalized Analysis of the Effects of Additional Input and Output reactions to a Linear Pathway

Journal of theoretical biology, 2002-03, Vol.215 (2), p.239-251

2002

Link zum Volltext

Verfügbarkeit prüfen

Carbon flux analysis in a pantothenate overproducing Corynebacterium glutamicum strain

Molecular biology reports, 2002-01, Vol.29 (1-2), p.129-134

2002

Link zum Volltext

Verfügbarkeit prüfen

Should personalised dosing have a role in cancer treatment?

Frontiers in oncology, 2023-05, Vol.13, p.1154493-1154493

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5699: Development and validation of a quantitative systems pharmacology model for prediction of preclinical efficacy of PARP inhibitors rucaparib and talazoparib combined with the ATR inhibitor gartisertib (M4344)

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5699-5699

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract A36: An anticancer drug combination and regimen database for research and clinical optimization

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.A36-A36

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(17)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An integrated study of threonine-pathway enzyme kinetics in Escherichia coli

Dynamic modeling of the central carbon metabolism of Escherichia coli

Control of the threonine-synthesis pathway in Escherichia coli: a theoretical and experimental approach

565 The Virtual Tumour, a predictive simulation platform to optimize anti-cancer drug scheduling and combination

Using a mammalian cell cycle simulation to interpret differential kinase inhibition in anti-tumour pharmaceutical development

Threonine synthesis from aspartate in Escherichia coli cell-free extracts: pathway dynamics

Rational Design of a Corynebacterium glutamicum Pantothenate Production Strain and Its Characterization by Metabolic Flux Analysis and Genome-Wide Transcriptional Profiling

Ketopantoate reductase activity is only encoded by ilvC in Corynebacterium glutamicum

Metabolic network analysis during fed-batch cultivation of Corynebacterium glutamicum for pantothenic acid production: first quantitative data and analysis of by-product formation

In silico strategy to rationally engineer metabolite production: a case study for threonine in Escherichia coli

Control of threonine pathway in E. coli. Application to biotechnologies

Dynamic simulation of pollutant effects on the threonine pathway in Escherichia coli

Parameters estimation by differential evolutionary algorithms for simulation of metabolic pathways in Escherichia coli

Dependence of Control Coefficient Distribution on the Boundaries of a Metabolic System: A Generalized Analysis of the Effects of Additional Input and Output reactions to a Linear Pathway

Carbon flux analysis in a pantothenate overproducing Corynebacterium glutamicum strain

Should personalised dosing have a role in cancer treatment?

Abstract 5699: Development and validation of a quantitative systems pharmacology model for prediction of preclinical efficacy of PARP inhibitors rucaparib and talazoparib combined with the ATR inhibitor gartisertib (M4344)

Abstract A36: An anticancer drug combination and regimen database for research and clinical optimization

Suchergebnisse filtern